David Diller - Concepedia

Author

David Diller

University of Washington ORCID

Also Known As

D. Diller, D. J. Diller, David Diller, David J Diller, David J. Diller, Diller, David E.

120

Publications

2.1K

Citations

H-Index

110

Concepts

All Affiliations

University of Washington American Pharmacists Association Howard Hughes Medical Institute LAC+USC Medical Center Princeton University

About

David Diller is an author at University of Washington specializing in medicine, drug discovery, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	910
2	Engineering	10	10	630
3	Natural Sciences	9	9	432
4	Management	1	1	15
5	Public Health	1	1	101

David Diller

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
High throughput docking for library design and library prioritization David Diller, Kenneth M. Merz Proteins Structure Function and Bioinformatics EngineeringCombinatorial LibrariesHigh ThroughputComputer ArchitectureMolecular Biology	2001	335
Characterization of Chemical Libraries for Luciferase Inhibitory Activity Douglas S. Auld, Noel Southall, Ajit Jadhav, Journal of Medicinal Chemistry	2008	189
Representation and reasoning for DAML-based policy and domain services in KAoS and nomads Jeffrey M. Bradshaw, Andrzej Uszok, Renia Jeffers,	2003	132
Kinases, Homology Models, and High Throughput Docking David Diller, Rixin Li Journal of Medicinal Chemistry Homology ModelsDrug TargetMedicineNatural SciencesComputational Biology	2003	117
Improved Naïve Bayesian Modeling of Numerical Data for Absorption, Distribution, Metabolism and Excretion (ADME) Property Prediction Anthony E. Klon, Jeffrey F. Lowrie, David Diller Journal of Chemical Information and Modeling Bayesian StatisticEngineeringMachine LearningProperty PredictionClassification Method	2006	101
5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase Chunjian Liu, Stephen T. Wrobleski, James C. Lin, Journal of Medicinal Chemistry 5-Cyanopyrimidine DerivativesDrug TargetP38 InhibitorsCellular PharmacologyPharmacotherapy	2005	70
Use of Catalyst Pharmacophore Models for Screening of Large Combinatorial Libraries Evan A. Hecker, Chaya Duraiswami, Tariq A. Andrea, Journal of Chemical Information and Computer Sciences Combinatorial ChemistryTargeted LibraryMedicinal ChemistryBioorganic ChemistryLibrary Prioritization	2002	65
Insights for Predicting Blood-Brain Barrier Penetration of CNS Targeted Molecules Using QSPR Approaches Yi Fan, Rayomand J. Unwalla, R. Aldrin Denny, Journal of Chemical Information and Modeling Drug TargetBrain PenetrationSecretase InhibitorsNeurochemical BiomarkersPre-clinical Pharmacology	2010	65
The Role of Waters in Docking Strategies with Incremental Flexibility for Carbohydrate Derivatives: Heat-Labile Enterotoxin, a Multivalent Test Case Wendy E. Minke, David Diller, Wim G. J. Hol, Journal of Medicinal Chemistry	1999	62
The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase Katerina Leftheris, Gulzar Ahmed, Ran Chan, Journal of Medicinal Chemistry P38 Map KinaseTriaminotriazine AnilinePharmacotherapyChemical BiologyPharmaceutical Chemistry	2004	50

Page 1